Cover Image
市場調查報告書

感染疾病監測解決方案的全球市場預測 2021年:醫院、LTC (長期照護) 設施、養老院、高度護理設施、附看護住宅

Infection Surveillance Solutions Market by Product (Software (On Premise, Web Based), Services (Training & Consulting, Implementation)), End User (Hospitals, LTCs, Nursing Home, Skilled Nursing Facility, Assisted Living) - Global Forecast to 2021

出版商 MarketsandMarkets 商品編碼 360817
出版日期 內容資訊 英文 194 Pages
訂單完成後即時交付
價格
Back to Top
感染疾病監測解決方案的全球市場預測 2021年:醫院、LTC (長期照護) 設施、養老院、高度護理設施、附看護住宅 Infection Surveillance Solutions Market by Product (Software (On Premise, Web Based), Services (Training & Consulting, Implementation)), End User (Hospitals, LTCs, Nursing Home, Skilled Nursing Facility, Assisted Living) - Global Forecast to 2021
出版日期: 2016年06月14日 內容資訊: 英文 194 Pages
簡介

全球感染疾病監測解決方案市場,預計從2016年到2021年以14.1%的年複合成長率成長,到2021年達到5億880萬美元的規模。該市場主要由於醫療相關感染 (HAI)的發病率增加,政府的預防HAI政策,醫療費的增加,及手術數的增加等要素,預計受促進。可是,軟體的高成本,醫療專家之間對於導入先進醫療工具的猶豫,及醫療產業上熟練的IT專家不足等,預計某種程度抑制感染疾病監測解決方案市場的成長。

本報告提供全球感染疾病監測解決方案市場的相關調查,各種類、階段、終端用戶、用途、地區的市場規模的變化與預測,市場成長的各種影響因素及市場機會分析,競爭環境與市場佔有率,及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 感染疾病監測解決方案市場概要
  • 北美:感染疾病監測解決方案市場:各產品
  • 地區概要:感染疾病監測解決方案市場
  • 北美壟斷感染疾病監測解決方案市場
  • 感染疾病監測解決方案市場:新興國家 vs. 已開發國家

第5章 市場概要

  • 簡介
  • 市場區隔
    • 各產品與服務
    • 各終端用戶
  • 市場動態
    • 促進要素
    • 阻礙要素
    • 機會
    • 課題
  • 產業趨勢
  • 主要的購買標準

第6章 全球感染疾病監測解決方案市場:各產品

  • 簡介
  • 軟體
    • 本地安裝軟體
    • 網站型軟體
  • 服務
    • 產品支援、維修服務
    • 訓練、諮詢服務
    • 實行服務

第7章 全球感染疾病監測解決方案市場:各終端用戶

  • 簡介
  • 醫院
    • 大規模醫院
    • 中規模醫院
    • 小規模醫院
  • 長期選擇照護
    • 養老院
    • 高度護理設施
    • 附看護住宅
  • 其他終端用戶

第8章 全球感染疾病監測解決方案市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第9章 競爭環境

  • 概要
  • 主要企業
  • 競爭情形、趨勢

第10章 企業簡介 (產業概要、產品、近幾年的發展、MNM的見解)

  • 簡介
  • BECTON, DIKINSON AND COMPANY
  • PREMIER INC.
  • WOLTERS KLUWER N.V.
  • BAXTER INTERNATIONAL INC.
  • GOJO INDUSTRIES, INC.
  • RL SOLUTIONS
  • TRUVEN HEALTH ANALYTICS (AN IBM COMPANY)
  • DEB GROUP LTD.
  • HYGREEN, INC.
  • ATLAS MEDICAL SOFTWARE

第11章 附錄

圖表

目錄
Product Code: HIT 4380

The global infection surveillance solutions market is expected to grow at a CAGR of 14.1% during the forecast period of 2016-2021 and is estimated at USD 508.8 million in 2021. The market is mainly driven by factors such as increasing incidence of healthcare-associated infections (HAIs), government policies for preventing HAIs, rising healthcare expenditure, and increasing number of surgeries. However, factors such as high cost of software, reluctance among medical professionals to adopt advanced healthcare tools, and dearth of skilled IT professionals in the healthcare industry are expected to restrain the growth of the infection surveillance solutions market to a certain extent.

In this report, the global infection surveillance solutions market is segmented by product, end user, and region.

On the basis of products, the market is classified into software and services. The software segment is further segmented into on-premise and web-based software. The services included in this report are subdivided into product support & maintenance, training & consulting, and implementation services. By end user, the infection surveillance solutions market is segmented into hospitals and long-term care facilities. Hospitals are further sub-divided on the basis of bed size into large, medium-sized, and small hospitals. Long-term care facilities included in this report are nursing homes, skilled nursing facilities, and assisted living facilities.

Geographically, North America accounted for the largest share of the global infection surveillance solutions market in 2015, followed by Europe, Asia-Pacific, and the RoW. Developed geographies like North America and Europe are likely to grow at a lower CAGR as compared to the Asia-Pacific market. The Asia-Pacific region is expected to record the highest market growth during the forecast period due to the rising incidences of HAIs, increased awareness and accessibility to advanced healthcare facilities, rising healthcare spending, and rapid improvements in the health insurance sector in this region.

In 2015, Becton, Dickinson and Company (U.S.), Premier Inc. (U.S.), Wolters Kluwer N.V. (Netherlands,), Baxter International Inc. (U.S.), and GOJO Industries, Inc. (U.S.) among others, were the leading players in the infection surveillance solutions market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the infection surveillance solutions market. The report analyzes the infection surveillance solutions market by product and end user across all regions
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and new product launches in the infection surveillance solutions market
  • Market Development: Comprehensive information of the lucrative emerging markets by product, end user, and region
  • Market Diversification: Exhaustive information of new products, growing regions, recent developments, and investments in the global infection surveillance solutions market
  • Competitive Assessment: In-depth assessment of growth strategies, products, distribution networks, and manufacturing capabilities of the leading players in the global infection surveillance solutions market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. SECONDARY SOURCES
    • 2.4.1. KEY DATA FROM SECONDARY SOURCES
  • 2.5. PRIMARY SOURCES
    • 2.5.1. KEY DATA FROM PRIMARY SOURCES
    • 2.5.2. KEY INDUSTRY INSIGHTS FROM PRIMARY SOURCES
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. INFECTION SURVEILLANCE SOLUTIONS MARKET OVERVIEW
  • 4.2. NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT
  • 4.3. GEOGRAPHIC SNAPSHOT: INFECTION SURVEILLANCE SOLUTIONS MARKET
  • 4.4. NORTH AMERICA TO DOMINATE THE INFECTION SURVEILLANCE SOLUTIONS MARKET DURING THE FORECAST PERIOD
  • 4.5. INFECTION SURVEILLANCE SOLUTIONS MARKET: DEVELOPING VS. DEVELOPED COUNTRIES

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. BY PRODUCTS & SERVICES
    • 5.2.2. BY END USER
  • 5.3. MARKET DYNAMICS
    • 5.3.1. MARKET DRIVERS
      • 5.3.1.1. Increasing incidence of HAIs
      • 5.3.1.2. Government policies for preventing HAIs
      • 5.3.1.3. Increasing healthcare expenditure
      • 5.3.1.4. Increasing number of surgeries
    • 5.3.2. MARKET RESTRAINTS
      • 5.3.2.1. High cost of software
      • 5.3.2.2. Reluctance among medical professionals to adopt advanced healthcare tools
      • 5.3.2.3. Dearth of skilled IT professionals in the healthcare industry
    • 5.3.3. MARKET OPPORTUNITIES
      • 5.3.3.1. Cloud-based software offers significant growth opportunities
      • 5.3.3.2. High growth in developing counties across APAC and Latin America
    • 5.3.4. MARKET CHALLENGES
      • 5.3.4.1. Under developed IT infrastructure in developing countries
  • 5.4. INDUSTRY TRENDS
    • 5.4.1. SHIFT TOWARDS AUTOMATION IN HEALTHCARE FACILITIES
    • 5.4.2. GROWING DEMAND FOR WEB-BASED SOLUTIONS AND MOBILE PLATFORMS
  • 5.5. KEY BUYING CRITERIA

6. GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. SOFTWARE
    • 6.2.1. ON-PREMISE SOFTWARE
    • 6.2.2. WEB-BASED SOFTWARE
  • 6.3. SERVICES
    • 6.3.1. PRODUCT SUPPORT & MAINTENANCE SERVICES
    • 6.3.2. TRAINING & CONSULTING SERVICES
    • 6.3.3. IMPLEMENTATION SERVICES

7. GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER

  • 7.1. INTRODUCTION
  • 7.2. HOSPITALS
    • 7.2.1. LARGE HOSPITALS
    • 7.2.2. MEDIUM-SIZED HOSPITALS
    • 7.2.3. SMALL HOSPITALS
  • 7.3. LONG-TERM CARE FACILITIES
    • 7.3.1. NURSING HOMES
    • 7.3.2. SKILLED NURSING FACILITIES
    • 7.3.3. ASSISTED LIVING FACILITIES
  • 7.4. OTHER END USERS

8. GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION

  • 8.1. INTRODUCTION
  • 8.2. NORTH AMERICA
    • 8.2.1. U.S.
    • 8.2.2. CANADA
  • 8.3. EUROPE
    • 8.3.1. GERMANY
    • 8.3.2. FRANCE
    • 8.3.3. U.K.
    • 8.3.4. ITALY
    • 8.3.5. SPAIN
    • 8.3.6. REST OF EUROPE
  • 8.4. ASIA-PACIFIC
    • 8.4.1. JAPAN
    • 8.4.2. CHINA
    • 8.4.3. INDIA
    • 8.4.4. REST OF ASIA-PACIFIC
  • 8.5. REST OF THE WORLD
    • 8.5.1. LATIN AMERICA
    • 8.5.2. MIDDLE EAST AND AFRICA

9. COMPETITIVE LANDSCAPE

  • 9.1. OVERVIEW
  • 9.2. LEADING PLAYERS IN THE INFECTION SURVEILLANCE SOLUTIONS MARKET
  • 9.3. COMPETITIVE SITUATION AND TRENDS
    • 9.3.1. PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
    • 9.3.2. PRODUCT ENHANCEMENTS
    • 9.3.3. ACQUISITIONS
    • 9.3.4. NEW PRODUCT LAUNCHES
    • 9.3.5. EXPANSIONS

10. COMPANY PROFILES (Business Overview, Products, Company Snapshot, Recent Developments, MnM View)*

  • 10.1. INTRODUCTION
  • 10.2. BECTON, DIKINSON AND COMPANY
  • 10.3. PREMIER INC.
  • 10.4. WOLTERS KLUWER N.V.
  • 10.5. BAXTER INTERNATIONAL INC.
  • 10.6. GOJO INDUSTRIES, INC.
  • 10.7. RL SOLUTIONS
  • 10.8. TRUVEN HEALTH ANALYTICS (AN IBM COMPANY)
  • 10.9. DEB GROUP LTD.
  • 10.10. HYGREEN, INC.
  • 10.11. ATLAS MEDICAL SOFTWARE

*Details on company financial might not be captured in case of unlisted companies

11. APPENDIX

  • 11.1. INSIGHTS OF INDUSTRY EXPERTS
  • 11.2. DISCUSSION GUIDE
  • 11.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 11.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 11.5. AVAILABLE CUSTOMIZATIONS
  • 11.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: INFECTION SURVEILLANCE SOLUTIONS MARKET SNAPSHOT, 2016 VS. 2021
  • TABLE 2: PRINCIPAL OPERATIVE PROCEDURES WITH HIGH RISK OF SSIS
  • TABLE 3: GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 4: GLOBAL INFECTION SURVEILLANCE SOFTWARE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 5: GLOBAL INFECTION SURVEILLANCE SOFTWARE MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 6: GLOBAL ON-PREMISE INFECTION SURVEILLANCE SOFTWARE MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 7: GLOBAL WEB-BASED INFECTION SURVEILLANCE SOFTWARE MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 8: GLOBAL INFECTION SURVEILLANCE SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 9: GLOBAL INFECTION SURVEILLANCE SERVICES MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 10: GLOBAL PRODUCT SUPPORT & MAINTENANCE SERVICES MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 11: GLOBAL TRAINING AND CONSULTING SERVICES MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 12: GLOBAL IMPLEMENTATION SERVICES MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 13: GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 14: GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 15: GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 16: GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LARGE HOSPITALS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 17: GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR MEDIUM-SIZED HOSPITALS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 18: GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR SMALL HOSPITALS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 19: GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014-2021(USD MILLION)
  • TABLE 20: GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 21: GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR NURSING HOMES, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 22: GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR SKILLED NURSING FACILITIES, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 23: GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR ASSISTED LIVING FACILITIES, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 24: GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR OTHER END USERS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 25: GLOBAL: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 26: NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION
  • TABLE 27: NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 28: NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014-2021 (USD MILLION)
  • TABLE 29: NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICE TYPE, 2014-2021 (USD MILLION)
  • TABLE 30: NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 31: NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 32: NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 33: U.S.: MARKET INDICATORS
  • TABLE 34: U.S.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 35: U.S.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014-2021 (USD MILLION)
  • TABLE 36: U.S.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014-2021 (USD MILLION)
  • TABLE 37: U.S.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 38: U.S.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 39: U.S.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 40: CANADA: MARKET INDICATORS
  • TABLE 41: CANADA.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 42: CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014-2021 (USD MILLION)
  • TABLE 43: CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014-2021 (USD MILLION)
  • TABLE 44: CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 45: CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 46: CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 47: EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION
  • TABLE 48: EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 49: EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014-2021 (USD MILLION)
  • TABLE 50: EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014-2021 (USD MILLION)
  • TABLE 51: EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 52: EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 53: EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 54: GERMANY: MARKET INDICATORS
  • TABLE 55: GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 56: GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014-2021 (USD MILLION)
  • TABLE 57: GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014-2021 (USD MILLION)
  • TABLE 58: GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 59: GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 60: GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 61: FRANCE: MARKET INDICATORS
  • TABLE 62: FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 63: FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014-2021 (USD MILLION)
  • TABLE 64: FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014-2021 (USD MILLION)
  • TABLE 65: FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 66: FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 67: FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 68: U.K.: MARKET INDICATORS
  • TABLE 69: U.K.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 70: U.K.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014-2021 (USD MILLION)
  • TABLE 71: U.K.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014-2021 (USD MILLION)
  • TABLE 72: U.K.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 73: U.K.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 74: U.K.: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 75: ITALY: MARKET INDICATORS
  • TABLE 76: ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 77: ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014-2021 (USD MILLION)
  • TABLE 78: ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014-2021 (USD MILLION)
  • TABLE 79: ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 80: ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 81: ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 82: SPAIN: MARKET INDICATORS
  • TABLE 83: SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 84: SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014-2021 (USD MILLION)
  • TABLE 85: SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014-2021 (USD MILLION)
  • TABLE 86: SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 87: SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 88: SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 89: ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 90: ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014-2021 (USD MILLION)
  • TABLE 91: ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014-2021 (USD MILLION)
  • TABLE 92: ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 93: ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 94: ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 95: APAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 96: APAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 97: APAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014-2021 (USD MILLION)
  • TABLE 98: APAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014-2021 (USD MILLION)
  • TABLE 99: APAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 100: APAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 101: APAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 102: JAPAN: MARKET INDICATORS
  • TABLE 103: JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 104: JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014-2021 (USD MILLION)
  • TABLE 105: JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014-2021 (USD MILLION)
  • TABLE 106: JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 107: JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 108: JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 109: CHINA: MARKET INDICATORS
  • TABLE 110: CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 111: CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014-2021 (USD MILLION)
  • TABLE 112: CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014-2021 (USD MILLION)
  • TABLE 113: CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 114: CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 115: CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 116: INDIA: MARKET INDICATORS
  • TABLE 117: INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 118: INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014-2021 (USD MILLION)
  • TABLE 119: INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014-2021 (USD MILLION)
  • TABLE 120: INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 121: INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 122: INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 123: ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 124: ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014-2021 (USD MILLION)
  • TABLE 125: ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014-2021 (USD MILLION)
  • TABLE 126: ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 127: ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 128: ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 129: ROW: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 130: ROW: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 131: ROW: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014-2021 (USD MILLION)
  • TABLE 132: ROW: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014-2021 (USD MILLION)
  • TABLE 133: ROW: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 134: ROW: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 135: ROW: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 136: LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 137: LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014-2021 (USD MILLION)
  • TABLE 138: LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014-2021 (USD MILLION)
  • TABLE 139: LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 140: LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 141: LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 142: MIDDLE EAST AND AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 143: MIDDLE EAST AND AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SOFTWARE TYPE, 2014-2021 (USD MILLION)
  • TABLE 144: MIDDLE EAST AND AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY SERVICES TYPE, 2014-2021 (USD MILLION)
  • TABLE 145: MIDDLE EAST AND AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 146: MIDDLE EAST AND AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 147: MIDDLE EAST AND AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 148: KEY PLAYERS IN THE GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET
  • TABLE 149: GROWTH STRATEGY MATRIX (2012-2016)
  • TABLE 150: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2013-2015
  • TABLE 151: PRODUCT ENHANCEMENTS, 2012-2015
  • TABLE 152: ACQUISITIONS, 2014-2016
  • TABLE 153: NEW PRODUCT LAUNCHES, 2013-2015
  • TABLE 154: EXPANSIONS, 2013-2015

LIST OF FIGURES

  • FIGURE 1: INFECTION SURVEILLANCE SOLUTIONS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 7: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY PRODUCT, 2016 VS. 2021 (USD MILLION)
  • FIGURE 8: INFECTION SURVEILLANCE SOFTWARE MARKET SIZE, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 9: INFECTION SURVEILLANCE SERVICES MARKET SIZE, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 10: INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE, BY END USER, 2016 VS. 2021 (USD MILLION)
  • FIGURE 11: GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET SIZE FOR HOSPITALS, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 12: GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 13: GEOGRAPHIC ANALYSIS: GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET
  • FIGURE 14: INCREASING INCIDENCE OF HEALTHCARE-ASSOCIATED INFECTIONS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 15: U.S. HELD THE LARGEST SHARE OF THE NORTH AMERICAN INFECTION SURVEILLANCE SOLUTIONS MARKET IN 2015
  • FIGURE 16: CHINA & JAPAN PROVIDE HIGH GROWTH POTENTIAL FOR INFECTION SURVEILLANCE SOLUTIONS MARKET
  • FIGURE 17: INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHIC MIX
  • FIGURE 18: CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 19: INFECTION SURVEILLANCE SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20: COMMON HEALTHCARE-ASSOCIATED INFECTIONS IN THE U.S. ACUTE CARE HOSPITALS
  • FIGURE 21: GLOBAL HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 22: HEALTHCARE EXPENDITURE GROWTH RATE ACROSS KEY GEOGRAPHIES
  • FIGURE 23: KEY INDUSTRY TRENDS
  • FIGURE 24: GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT, 2016 VS. 2021 (USD MILLION)
  • FIGURE 25: GLOBAL INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 26: GLOBAL INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 27: GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2016 VS. 2021 (USD MILLION)
  • FIGURE 28: GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 29: GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 30: GEOGRAPHIC SNAPSHOT (2016-2021): ASIA-PACIFIC, AN EMERGING GROWTH HOTSPOT
  • FIGURE 31: NORTH AMERICAN INFECTION SURVEILLANCE SOLUTIONS MARKET SNAPSHOT, 2016
  • FIGURE 32: NORTH AMERICA: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 33: U.S.: DISTRIBUTION OF COMMON HEALTHCARE-ASSOCIATED INFECTIONS, 2012
  • FIGURE 34: U.S.: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 35: CANADA: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 36: EUROPE: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 37: GERMANY: DISTRIBUTION OF COMMON HEALTHCARE-ASSOCIATED INFECTIONS, 2012
  • FIGURE 38: GERMANY: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 39: FRANCE: DISTRIBUTION OF COMMON HEALTHCARE-ASSOCIATED INFECTIONS, 2012
  • FIGURE 40: FRANCE: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 41: U.K.: DISTRIBUTION OF COMMON HEALTHCARE-ASSOCIATED INFECTIONS, 2012
  • FIGURE 42: U.K.: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 43: ITALY: DISTRIBUTION OF COMMON HEALTHCARE-ASSOCIATED INFECTIONS, 2012
  • FIGURE 44: ITALY: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 45: SPAIN: DISTRIBUTION OF COMMON HEALTHCARE-ASSOCIATED INFECTIONS, 2012
  • FIGURE 46: SPAIN: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 47: ROE: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 48: ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTIONS MARKET SNAPSHOT, 2016
  • FIGURE 49: APAC: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 50: JAPAN: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 51: CHINA: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 52: INDIA: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 53: ROAPAC: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 54: LATIN AMERICA: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 55: MIDDLE EAST AND AFRICA: HEALTHCARE EXPENDITURE, 2003-2013
  • FIGURE 56: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS WERE THE KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS (2012-2016)
  • FIGURE 57: KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS (2012-2016)
  • FIGURE 58: GEOGRAPHIC REVENUE MIX OF THE TOP FOUR PLAYERS
  • FIGURE 59: COMPANY SNAPSHOT: BECTON, DIKINSON AND COMPANY
  • FIGURE 60: COMPANY SNAPSHOT: PREMIER INC.
  • FIGURE 61: COMPANY SNAPSHOT: WOLTERS KLUWER N.V.
  • FIGURE 62: COMPANY SNAPSHOT: BAXTER INTERNATIONAL INC.
Back to Top